Atara Biotherapeutics, Inc. (ATRA) Q3 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and thank you for standing by. Welcome to Atara Biotherapeutics third quarter 2023 financial results conference call. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please be advised that today's call is being recorded. I would now like to hand the call over to Alex Chapman, Vice President of Corporate Communications and Investor Relations at Atara Biotherapeutics. Please go ahead, sir. Thank you, Sherry. Good morning, everyone, and welcome to Atara's conference call to discuss our expanded TabCell global partnership with PFR Laboratories and our third quarter 2023 update. Earlier today, we issued a press release announcing this partnership and our third quarter financial results. This press release and an updated slide deck are available in the Investors in Media section at atarabio.com. Joining me on today's call are Dr. Pascal Tuchon, President and Chief Executive Officer and Eric Killingran, Chief Financial Officer. We will begin with prepared remarks, then open the call for your questions. We would like to remind listeners that during the call, the company's management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release and the company's SEC filings. These statements are made as of today's date, and the company undertakes no obligation to update these statements. Now, I'd like to turn the call over to Pascal. Pascal? Thank you, Alex, and thank you all for joining us this morning. Today, we ann...